The global Single Photon Emission Computed Tomography (SPECT) market is anticipated to witness high growth owing to increasing prevalence of chronic diseases such as cardiovascular diseases and cancer. SPECT is a nuclear imaging technique which uses gamma cameras and radiotracers to produce three-dimensional images. It finds wide application in neurology, oncology and cardiology for functional molecular imaging and detecting abnormalities in organ functions. The equipment provides high sensitivity scans thereby aiding timely diagnosis. Growing geriatric population prone to health issues and rising awareness about benefits of early disease detection are fueling adoption.

Key Takeaways

Key players operating in the Single Photon Emission Computed Tomography are GE Healthcare, Curium, Bracco Imaging, Bruker, MiE GmbH, Siemens Healthcare, Koninklijke Philips N.V., Medisco Ltd., Spectrum Dynamics Medical, NTP Radioisotopes SOC Ltd.

Some of the key opportunities in the Single Photon Emission Computed Tomography (SPECT) Market Demand include development of hybrid instruments integrated with CT and PET providing anatomical and functional imaging. Market players are investing in product innovation to introduce compact and portable devices for point-of-care diagnosis in ambulatory settings.

Global expansion is observed as major companies are establishing manufacturing plants and distribution networks in emerging countries of Asia Pacific and Latin America to tap into high potential markets. Favorable government policies supporting healthcare infrastructure upgradation are encouraging international players.

Market Drivers

- Increasing geriatric population prone to cancer and cardiac ailments driving demand for non-invasive diagnostic scans.

- Rising healthcare expenditure in developing nations enhancing access to advanced imaging modalities.

Market Restrains

- High installation and maintenance costs of SPECT systems limiting adoption in resource constrained settings.

- Shorter half-life of commonly used radiotracers requiring on-site cyclotron necessitating sizable capital investments.

Segment Analysis

The single photon emission computed tomography market is segmented by product into single photon emission computed tomography/computed tomography (SPECT/CT) systems and standalone SPECT systems. The SPECT/CT systems segment is dominating owing to its increased use in cardiology and oncology applications. SPECT/CT systems provide morphological and functional imaging capabilities with high sensitivity and resolution. This aids clinicians in disease diagnosis and management.

Global Analysis

Regionally, North America holds the largest share in the single photon emission computed tomography market due to advancements in nuclear imaging technologies and availability of radiotracers. Growing geriatric population and higher adoption of technologically advanced systems drive market growth in the region. The Asia Pacific region is expected to grow at the fastest pace during the forecast period owing to increased healthcare spending, growing awareness about early disease diagnosis, and developing healthcare infrastructure.

Get more insights on Single Photon Emission Computed Tomography Market